Home › Companies › NEUROGENE INC. › 2024-2025
Compiled from SEC Form N-PX filings and NEUROGENE INC.’s Form 8-K, filed 2025-06-12 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2024-2025 2025-2026
Explore NEUROGENE INC. in the interactive database Compare manager voting policies
These tallies are NEUROGENE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Sarah B. Noonberg | 10,344,227 | -- | -- | 656,571 | 480,734 | Majority: yes |
| Elect Director: Robert "Keith" Woods | 10,444,580 | -- | -- | 556,218 | 480,734 | Majority: yes |
| Proposal 2: Approval on an advisory (non-binding) basis of the compensation of the Company's named executive officers: | 7,721,866 | 3,174,484 | 104,448 | -- | 480,734 | Majority: yes |
| Proposal 3: Approval of an amendment to the Company's 2023 Equity Incentive Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase also includes shares issuable on exercise of prefunded warr | 8,067,746 | 2,829,550 | 103,502 | -- | 480,734 | Majority: yes |
| Proposal 4: Approval of an amendment to the Company's 2023 Employee Stock Purchase Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase also includes shares issuable on exercise of prefund | 10,794,908 | 101,329 | 104,561 | -- | 480,734 | Majority: yes |
| Proposal 5: Ratification on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025: | 11,372,327 | 10,333 | 98,872 | -- | -- | Majority: yes |
Source: NEUROGENE INC., Form 8-K, filed with the SEC on 2025-06-12 — read the filing on EDGAR.
Each item below shows how the 106 asset managers that disclosed a NEUROGENE INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 10 wordings of this item as funds reported it.
71% Majority: yes · of votes cast
NEUROGENE INC.’s own tally for this item (“Proposal 2: Approval on an advisory (non-binding) basis of the compensation of the Company's named executive officers:”): 7,721,866 for, 3,174,484 against, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 14,262,066 outstanding shares: 54.1% for, 22% against (76% of the company cast a for/against vote).
The 106 asset managers below cast 99.8% of the shares they voted on this item FOR (10,378,504 for, 14,790 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 1,717,127 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 1,285,179 | 0 | 0 | 0 | For |
| EcoR1 Capital, LLC | 1,186,381 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 1,133,656 | 0 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 962,740 | 0 | 0 | 0 | For |
| Commodore Capital LP | 925,000 | 0 | 0 | 0 | For |
| GREAT POINT PARTNERS LLC | 491,792 | 0 | 0 | 0 | For |
| BlackRock | 485,237 | 911 | 0 | 0 | For |
| Casdin Capital, LLC | 418,159 | 0 | 0 | 0 | For |
| ArrowMark Colorado Holdings LLC | 371,473 | 0 | 0 | 0 | For |
| Octagon Capital Advisors LP | 201,148 | 0 | 0 | 0 | For |
| Fidelity | 162,596 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 108,084 | 0 | 0 | 0 | For |
| BLAIR WILLIAM & CO/IL | 106,924 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 104,339 | 0 | 0 | 0 | For |
| State Street | 91,027 | 28 | 0 | 0 | For |
| Woodline Partners LP | 83,410 | 0 | 0 | 0 | For |
| JPMorgan | 76,112 | 0 | 0 | 0 | For |
| Northern Trust | 63,735 | 0 | 0 | 0 | For |
| Vanguard | 61,560 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 51,500 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 32,765 | 0 | 0 | 0 | For |
| ADAR1 Capital Management, LLC | 25,736 | 0 | 0 | 0 | For |
| Wellington | 25,043 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 24,261 | 0 | 0 | 0 | For |
Showing the 25 largest of 106 asset managers. See all 106 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
NEUROGENE INC.’s own tally for this item (“Proposal 4: Approval of an amendment to the Company's 2023 Employee Stock Purchase Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase also include”): 10,794,908 for, 101,329 against, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 14,262,066 outstanding shares: 76% for, 0.8% against (76% of the company cast a for/against vote).
The 34 asset managers below cast 21% of the shares they voted on this item FOR (130,204 for, 495,445 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 405,116 | 0 | 0 | Against |
| Fidelity | 66,566 | 20,408 | 0 | 0 | For |
| Vanguard | 51,987 | 0 | 0 | 0 | For |
| Lincoln Financial | 9,100 | 6,668 | 0 | 0 | For |
| Equitable | 0 | 8,792 | 0 | 0 | Against |
| Northern Trust | 0 | 8,788 | 0 | 0 | Against |
| Global X | 0 | 6,847 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 6,074 | 0 | 0 | Against |
| Charles Schwab | 0 | 5,790 | 0 | 0 | Against |
| Pacific Life | 0 | 4,572 | 0 | 0 | Against |
| ETFis Series Trust I | 0 | 4,159 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 3,588 | 0 | 0 | Against |
| Voya | 0 | 2,046 | 0 | 0 | Against |
| Brighthouse | 0 | 1,750 | 0 | 0 | Against |
| SEI | 0 | 1,700 | 0 | 0 | Against |
| State Street | 1,658 | 0 | 0 | 0 | For |
| ProShares | 0 | 1,650 | 0 | 0 | Against |
| Victory Capital | 0 | 1,475 | 0 | 0 | Against |
| DWS | 0 | 1,099 | 0 | 0 | Against |
| Calvert | 0 | 1,009 | 0 | 0 | Against |
| Franklin Templeton | 0 | 1,003 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 818 | 0 | 0 | Against |
| Dimensional | 0 | 721 | 0 | 0 | Against |
| Nationwide | 0 | 504 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 396 | 0 | 0 | Against |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 2 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
NEUROGENE INC.’s own tally for this item (“Proposal 3: Approval of an amendment to the Company's 2023 Equity Incentive Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase also includes share”): 8,067,746 for, 2,829,550 against, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 14,262,066 outstanding shares: 57% for, 20% against (76% of the company cast a for/against vote).
The 34 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 625,649 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 405,116 | 0 | 0 | Against |
| Fidelity | 0 | 86,974 | 0 | 0 | Against |
| Vanguard | 0 | 51,987 | 0 | 0 | Against |
| Lincoln Financial | 0 | 15,768 | 0 | 0 | Against |
| Equitable | 0 | 8,792 | 0 | 0 | Against |
| Northern Trust | 0 | 8,788 | 0 | 0 | Against |
| Global X | 0 | 6,847 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 6,074 | 0 | 0 | Against |
| Charles Schwab | 0 | 5,790 | 0 | 0 | Against |
| Pacific Life | 0 | 4,572 | 0 | 0 | Against |
| ETFis Series Trust I | 0 | 4,159 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 3,588 | 0 | 0 | Against |
| Voya | 0 | 2,046 | 0 | 0 | Against |
| Brighthouse | 0 | 1,750 | 0 | 0 | Against |
| SEI | 0 | 1,700 | 0 | 0 | Against |
| State Street | 0 | 1,658 | 0 | 0 | Against |
| ProShares | 0 | 1,650 | 0 | 0 | Against |
| Victory Capital | 0 | 1,475 | 0 | 0 | Against |
| DWS | 0 | 1,099 | 0 | 0 | Against |
| Calvert | 0 | 1,009 | 0 | 0 | Against |
| Franklin Templeton | 0 | 1,003 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 818 | 0 | 0 | Against |
| Dimensional | 0 | 721 | 0 | 0 | Against |
| Nationwide | 0 | 504 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 396 | 0 | 0 | Against |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
NEUROGENE INC.’s own tally for this item (“Elect Director: Robert "Keith" Woods”): 10,444,580 for, 556,218 withheld, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 14,262,066 outstanding shares: 73% for, 4% withheld (77% of the company cast a for/withheld vote).
The 33 asset managers below cast 100% of the shares they voted on this item FOR (598,384 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 405,116 | 0 | 0 | 0 | For |
| Fidelity | 86,974 | 0 | 0 | 0 | For |
| Vanguard | 51,987 | 0 | 0 | 0 | For |
| Lincoln Financial | 15,768 | 0 | 0 | 0 | For |
| Equitable | 2,082 | 0 | 6,710 | 0 | Abstain |
| Northern Trust | 8,788 | 0 | 0 | 0 | For |
| Global X | 6,847 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 6,074 | 0 | Abstain |
| Charles Schwab | 5,790 | 0 | 0 | 0 | For |
| Pacific Life | 4,572 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 4,159 | 0 | Abstain |
| Bridge Builder Trust | 3,588 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 2,046 | 0 | Abstain |
| Brighthouse | 0 | 0 | 1,750 | 0 | Abstain |
| SEI | 1,700 | 0 | 0 | 0 | For |
| State Street | 1,658 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 1,650 | 0 | Abstain |
| Victory Capital | 0 | 0 | 1,475 | 0 | Abstain |
| DWS | 0 | 0 | 1,099 | 0 | Abstain |
| Calvert | 0 | 0 | 1,009 | 0 | Abstain |
| Franklin Templeton | 1,003 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 818 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 721 | 0 | Abstain |
| Nationwide | 504 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 396 | 0 | 0 | 0 | For |
Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
NEUROGENE INC.’s own tally for this item (“Elect Director: Sarah B. Noonberg”): 10,344,227 for, 656,571 withheld, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 14,262,066 outstanding shares: 73% for, 5% withheld (77% of the company cast a for/withheld vote).
The 33 asset managers below cast 100% of the shares they voted on this item FOR (155,670 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 405,116 | 0 | Abstain |
| Fidelity | 86,974 | 0 | 0 | 0 | For |
| Vanguard | 0 | 0 | 51,987 | 0 | Abstain |
| Lincoln Financial | 15,768 | 0 | 0 | 0 | For |
| Equitable | 6,710 | 0 | 2,082 | 0 | For |
| Northern Trust | 8,788 | 0 | 0 | 0 | For |
| Global X | 6,847 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,074 | 0 | 0 | 0 | For |
| Charles Schwab | 5,790 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 0 | 4,572 | 0 | Abstain |
| ETFis Series Trust I | 4,159 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 3,588 | 0 | Abstain |
| Voya | 2,046 | 0 | 0 | 0 | For |
| Brighthouse | 1,750 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| State Street | 1,658 | 0 | 0 | 0 | For |
| ProShares | 1,650 | 0 | 0 | 0 | For |
| Victory Capital | 1,475 | 0 | 0 | 0 | For |
| DWS | 1,099 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 1,009 | 0 | Abstain |
| Franklin Templeton | 1,003 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 818 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 721 | 0 | Abstain |
| Nationwide | 0 | 0 | 504 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 396 | 0 | Abstain |
Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.
99.9% Majority: yes · of votes cast
NEUROGENE INC.’s own tally for this item (“Proposal 5: Ratification on an advisory (non-binding) basis of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025:”): 11,372,327 for, 10,333 against, per its Form 8-K filed 2025-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 14,262,066 outstanding shares: 80% for, 0.1% against (80% of the company cast a for/against vote).
The 33 asset managers below cast 100% of the shares they voted on this item FOR (625,645 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 405,116 | 0 | 0 | 0 | For |
| Fidelity | 86,974 | 0 | 0 | 0 | For |
| Vanguard | 51,987 | 0 | 0 | 0 | For |
| Lincoln Financial | 15,768 | 0 | 0 | 0 | For |
| Equitable | 8,792 | 0 | 0 | 0 | For |
| Northern Trust | 8,788 | 0 | 0 | 0 | For |
| Global X | 6,847 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,074 | 0 | 0 | 0 | For |
| Charles Schwab | 5,790 | 0 | 0 | 0 | For |
| Pacific Life | 4,572 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 4,159 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 3,588 | 0 | 0 | 0 | For |
| Voya | 2,046 | 0 | 0 | 0 | For |
| Brighthouse | 1,750 | 0 | 0 | 0 | For |
| SEI | 1,700 | 0 | 0 | 0 | For |
| State Street | 1,658 | 0 | 0 | 0 | For |
| ProShares | 1,650 | 0 | 0 | 0 | For |
| Victory Capital | 1,475 | 0 | 0 | 0 | For |
| DWS | 1,099 | 0 | 0 | 0 | For |
| Calvert | 1,009 | 0 | 0 | 0 | For |
| Franklin Templeton | 1,003 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 818 | 0 | 0 | 0 | For |
| Dimensional | 721 | 0 | 0 | 0 | For |
| Nationwide | 504 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 396 | 0 | 0 | 0 | For |
Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.
Ranked by the number of NEUROGENE INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 14,262,066 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Samsara BioCapital, LLC | 12.04% |
| 2 | Redmile Group, LLC | 9.01% |
| 3 | EcoR1 Capital, LLC | 8.32% |
| 4 | RTW INVESTMENTS, LP | 7.95% |
| 5 | BAKER BROS. ADVISORS LP | 6.75% |
| 6 | Commodore Capital LP | 6.49% |
| 7 | GREAT POINT PARTNERS LLC | 3.45% |
| 8 | BlackRock | 3.41% |
| 9 | Casdin Capital, LLC | 2.93% |
| 10 | ArrowMark Colorado Holdings LLC | 2.60% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Samsara BioCapital, L.P. | 12.14% | DEF14A |
| Redmile Group, LLC | 10.92% | 13G |
| RTW Investments, LP | 10.51% | 13G |
| Entities affiliated with EcoR1 Capital Fund, L.P. | 10.12% | DEF14A |
| EcoR1 Capital, LLC | 10.12% | 13G |
| Entities affiliated with Redmile Group, LLC | 10.08% | DEF14A |
| Entities affiliated with RTW Investments, LP | 10.06% | DEF14A |
| Rachel McMinn | 9.26% | DEF14A |
| Casdin Capital, LLC | 9.08% | 13G |
| Entities affiliated with Casdin Capital, LLC | 9.08% | DEF14A |
Percentages above are of 14,262,066 shares outstanding, as reported by NEUROGENE INC. on its Form 10-Q dated 2025-05-05 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NEUROGENE INC.’s 10-Q dated 2025-05-05. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At NEUROGENE INC.'s shareholder meeting held 2025-06-12, in the 2024-2025 proxy season, 106 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 692 separate fund positions. On the most widely held item on that ballot — To approve on an an (non-binding) basis the compensation of the Company's named executive… — FOR was 71% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: NEUROGENE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-12.
NEUROGENE INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.